Advertisement
Screener

HEALTHCARE SERVICES GROUP, INC. (HCSG) Spending and interest coverage

HEALTHCARE SERVICES GROUP, INC. (HCSG) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.61%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months0.61%Share-based compensation / revenue. Period ending 2026-06-30.

$11.31M ÷ $1.86B × 100 ≈ 0.61%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue1.86B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation11.31M USDShare-based Payment Arrangement, Noncash Expense
Operating income(m)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$1.86B$11.31M(m)(m)(m)0.61%(m)(m)
2026-03-31(m)$1.85B$11.03M(m)(m)(m)0.60%(m)(m)
2025-12-31(m)$1.84B$12.01M(m)(m)(m)0.65%(m)(m)
2025-09-30(m)$1.81B$11.22M(m)(m)(m)0.62%(m)(m)
2025-06-30(m)$1.77B$10.85M(m)(m)(m)0.61%(m)(m)
2025-03-31(m)$1.74B$10.42M(m)(m)(m)0.60%(m)(m)
2024-12-31(m)$1.72B$9.16M(m)(m)(m)0.53%(m)(m)
2024-09-30(m)$1.70B$9.02M(m)(m)(m)0.53%(m)(m)
2024-06-30(m)$1.68B$9.17M(m)(m)(m)0.54%(m)(m)
2024-03-31(m)$1.68B$9.41M(m)(m)(m)0.56%(m)(m)
2023-12-31(m)$1.67B$8.98M(m)(m)(m)0.54%(m)(m)
2023-09-30(m)$1.67B$8.85M(m)(m)(m)0.53%(m)(m)
2023-06-30(m)$1.67B$8.86M(m)(m)(m)0.53%(m)(m)
2023-03-31(m)$1.68B$8.88M(m)(m)(m)0.53%(m)(m)
2022-12-31(m)$1.69B$9.21M(m)(m)(m)0.55%(m)(m)
2022-09-30(m)$1.69B$9.02M(m)(m)(m)0.53%(m)(m)
2022-06-30(m)$1.69B$9.03M(m)(m)(m)0.53%(m)(m)
2022-03-31(m)$1.66B$8.95M(m)(m)(m)0.54%(m)(m)
2021-12-31(m)$1.64B$8.83M(m)(m)(m)0.54%(m)(m)
2021-09-30(m)$1.64B$8.92M(m)(m)(m)0.54%(m)(m)
2021-06-30(m)$1.67B$8.52M(m)(m)(m)0.51%(m)(m)
2021-03-31(m)$1.72B$8.17M(m)(m)(m)0.48%(m)(m)
2020-12-31(m)$1.76B$7.87M(m)(m)(m)0.45%(m)(m)
2020-09-30(m)$1.78B$7.31M(m)(m)(m)0.41%(m)(m)
2020-06-30(m)(m)$7.13M(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)$7.00M(m)(m)(m)(m)(m)(m)
2019-12-31(m)$1.84B$6.87M(m)$3.46M(m)0.37%(m)Reported
2019-09-30(m)(m)$6.76M(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)$6.46M(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)$6.17M(m)(m)(m)(m)(m)(m)
2018-12-31(m)(m)$5.90M(m)(m)(m)(m)(m)(m)
2018-09-30(m)(m)$4.32M(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)$1.99M(m)(m)(m)(m)(m)(m)
2018-03-31(m)(m)$252.00K(m)(m)(m)(m)(m)(m)
2017-12-31(m)$1.87B$276.00K(m)(m)(m)0.01%(m)(m)
2017-09-30(m)(m)$2.26M(m)(m)(m)(m)(m)(m)
2017-06-30(m)(m)$3.58M(m)(m)(m)(m)(m)(m)
2017-03-31(m)(m)$4.09M(m)(m)(m)(m)(m)(m)
2016-12-31(m)$1.56B$4.25M(m)(m)(m)0.27%(m)(m)
2016-09-30(m)(m)$4.09M(m)(m)(m)(m)(m)(m)
2016-06-30(m)(m)$3.90M(m)(m)(m)(m)(m)(m)
2016-03-31(m)(m)$3.77M(m)(m)(m)(m)(m)(m)
2015-12-31(m)$1.44B$3.54M(m)(m)(m)0.25%(m)(m)
2015-09-30(m)(m)$3.37M(m)(m)(m)(m)(m)(m)
2015-06-30(m)(m)$3.28M(m)(m)(m)(m)(m)(m)
2015-03-31(m)(m)$3.20M(m)(m)(m)(m)(m)(m)
2014-12-31(m)$1.29B$3.08M(m)(m)(m)0.24%(m)(m)
2014-09-30(m)(m)$3.09M(m)(m)(m)(m)(m)(m)
2014-06-30(m)(m)$2.94M(m)(m)(m)(m)(m)(m)
2014-03-31(m)(m)$2.79M(m)(m)(m)(m)(m)(m)
2013-12-31(m)$1.15B$2.61M(m)(m)(m)0.23%(m)(m)
2013-09-30(m)(m)$2.63M(m)(m)(m)(m)(m)(m)
2013-06-30(m)(m)$2.59M(m)(m)(m)(m)(m)(m)
2013-03-31(m)(m)$2.56M(m)(m)(m)(m)(m)(m)
2012-12-31(m)$1.08B$2.54M(m)(m)(m)0.24%(m)(m)
2012-09-30(m)(m)$2.22M(m)(m)(m)(m)(m)(m)
2012-06-30(m)(m)$2.20M(m)(m)(m)(m)(m)(m)
2012-03-31(m)(m)$2.15M(m)(m)(m)(m)(m)(m)
2011-12-31(m)$889.07M$2.15M(m)(m)(m)0.24%(m)(m)
2011-09-30(m)(m)$2.02M(m)(m)(m)(m)(m)(m)
2011-06-30(m)(m)$1.82M(m)(m)(m)(m)(m)(m)
2011-03-31(m)(m)$1.63M(m)(m)(m)(m)(m)(m)
2010-12-31(m)(m)$1.33M(m)(m)(m)(m)(m)(m)
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-12-31(m)(m)$1.07M(m)(m)(m)(m)(m)(m)
2009-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31(m)(m)$563.00K(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
SONIDA SENIOR LIVING, INC. (SNDA)United States$1.803B-15.78
Brookdale Senior Living Inc. (BKD)United States$2.645B-27.78